Trump order signals shake-up in drug pricing innovation through Medicare and Medicaid
Biden-era policies rescinded by Donald Trump could signal a significant shake-up in Medicare and Medicaid drug price reforms.
JD Supra19h
CMS's New TCET Pathway Expedites Medicare Coverage for FDA Breakthrough Devices
The Centers for Medicare and Medicaid Services ("CMS") published a final notice outlining the processes and procedures for the Transitional ...
RFK Jr. second hearing takeaways: GOP criticism, more Medicare fumbles, and DEI
RFK Jr.'s second Senate confirmation hearing focused on vaccines, Medicare, diversity, and science. Key Republicans were reticent to show support.
Cowboys QB Dak Prescott supports effort to get cancer test covered by Medicare
Bill to pay for multi-cancer early detection screening test has bipartisan support, but just ran out of time last session.
Benefits Pro2h
Robert F. Kennedy Jr. worries anti-obesity drugs could ‘double insurance costs for employers’
President Donald Trump has nominated Kennedy to be the secretary of the U.S. Department of Health and Human Services, which ...
About half of Americans approve of using weight-loss drugs to treat obesity, AP-NORC poll finds
NORC Center for Public Affairs Research shows about half of U.S. adults believe it is a good thing for adults to use weight-loss drugs like Ozempic, Wegovy and other brands if they are struggling with ...
Benefits Pro8d
Trump administration pauses most CDC, HHS and CMS communications
The pause appears to apply to HHS agencies such as the U.S. Food and Drug Administration, the Centers for Medicare and Medicaid Services, the U.S. Centers for Disease Control and Prevention ...
JD Supra3d
Assessing the Impact of a Revoked Executive Order on a Medicaid Drug Demonstration Project
Of the scores of day-one executive orders (EOs) issued by President Trump, the order rescinding a Biden administration executive order on ...
Morningstar6d
Trump rolls back effort to lower Medicare, Medicaid drug costs
along with another program that would see Medicare pay less for drugs that receive accelerated approval from the Food and Drug Administration. The cell- and gene-therapy program, meanwhile ...
The Hill13d
Ozempic picked for Medicare price bargaining
these products are not considered generic versions and are not approved by the Food and Drug Administration. CMS had until Feb. 1 to publish the next round of drugs chosen for Medicare negotiation.